Refenesen Mucus Relief DM
NDC 10956-846, Dextromethorphan Hydrobromide / Guaifenesin, tablet, from Reese Pharmaceutical Co.
- Product NDC
- 10956-846
- Status
- Listed
- Labeler
- Reese Pharmaceutical Co
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M012
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/10956-846 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DEXTROMETHORPHAN HYDROBROMIDE20 mg/1
- GUAIFENESIN400 mg/1
Pharmacologic classes
Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]; Sigma-1 Agonist [EPC]; Sigma-1 Receptor Agonists [MoA]; Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]; Uncompetitive NMDA Receptor Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 10956-846-30 | 10956084630 | 1 BOTTLE in 1 CARTON (10956-846-30) / 30 TABLET in 1 BOTTLE |
| 10956-846-50 | 10956084650 | 1 BOTTLE in 1 CARTON (10956-846-50) / 50 TABLET in 1 BOTTLE |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 10956-846 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/10956-846 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 10956-846. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.